Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W4UQ
|
||||
Former ID |
DNC010329
|
||||
Drug Name |
(Z)-5-Amino-3-(4-methoxybenzylidene)indolin-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530673] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H14N2O2
|
||||
Canonical SMILES |
COC1=CC=C(C=C1)C=C2C3=C(C=CC(=C3)N)NC2=O
|
||||
InChI |
1S/C16H14N2O2/c1-20-12-5-2-10(3-6-12)8-14-13-9-11(17)4-7-15(13)18-16(14)19/h2-9H,17H2,1H3,(H,18,19)/b14-8-
|
||||
InChIKey |
DYCBCUFDDRQCID-ZSOIEALJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Proto-oncogene tyrosine-protein kinase receptor ret | Target Info | Inhibitor | [530673] | |
WikiPathways | SIDS Susceptibility Pathways | ||||
Dopaminergic Neurogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.